Observational

Effects of Active Hexose Correlated Compound on the Seasonal Variations of Immune Competence in Healthy Subjects 

This 2014 study was a 4-week, randomized, double-blind, parallel-group, and placebo-controlled study. It evaluated AHCC intake on immune competence in healthy individuals. The results show a significant increase in NK cell activity, while the placebo group showed a remarkable decline in NK cell activity.   References: Matsui, Y., Uhara, J., Satoi, S., Kaibori, M., Yamada, H., …

Effects of Active Hexose Correlated Compound on the Seasonal Variations of Immune Competence in Healthy Subjects  Read More »

10 Year Outcome of Enzyme Replacement Therapy with Agalsidase Beta in Patients with Fabry Disease. 

The aim of this study was to assess the clinical effect of α-galactosidase. Following supplementation, participants were assessed for severe clinical events, renal function and cardiac structure.   This 10-year study documents the effectiveness of agalsidase beta (1 mg/kg/2 weeks) in patients with Fabry disease. Most patients remained alive and event-free. Patients who initiated treatment at a younger …

10 Year Outcome of Enzyme Replacement Therapy with Agalsidase Beta in Patients with Fabry Disease.  Read More »

Scroll to Top